US FDA Leaves Pfizer’s Efficacy Data Out Of Under 5 EUA Due To ‘Data Maturity,’ Lack of ‘Confidence’

 
• By Sarah Karlin-Smith
  
spikevax and comirnaty
FDA authorized both Pfizer’s and Moderna’s COVID-19 vaccines for infants, toddlers and preschoolers on 17 June. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet